kynurenic acid has been researched along with Inflammatory Bowel Diseases in 3 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our aim was to determine the extent of inflammatory response and to influence the morphologic changes during the subacute phase of trinitro-benzene sulfonic acid (TNBS)-induced experimental colitis by oral phosphatidylcholine (PC) and N-methyl-D-aspartate (NMDA) receptor antagonist kynurenic acid therapy." | 3.78 | [Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease]. ( Boros, M; Erces, D; Ghyczy, M; Kaszaki, J; Kovács, T; Tiszlavicz, L; Tőkés, T; Varga, G; Vécsei, L, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kaya, B | 1 |
| Melhem, H | 1 |
| Niess, JH | 1 |
| Ye, Y | 1 |
| Zhang, X | 1 |
| Su, D | 1 |
| Ren, Y | 1 |
| Cheng, F | 1 |
| Yao, Y | 1 |
| Shi, G | 1 |
| Ji, Y | 1 |
| Chen, S | 1 |
| Shi, P | 1 |
| Dai, L | 1 |
| Su, X | 1 |
| Deng, H | 1 |
| Kovács, T | 1 |
| Varga, G | 1 |
| Erces, D | 1 |
| Tőkés, T | 1 |
| Tiszlavicz, L | 1 |
| Ghyczy, M | 1 |
| Vécsei, L | 1 |
| Boros, M | 1 |
| Kaszaki, J | 1 |
1 review available for kynurenic acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
GPR35 in Intestinal Diseases: From Risk Gene to Function.
Topics: Animals; Chemokines, CXC; Homeostasis; Humans; Inflammatory Bowel Diseases; Intestines; Kynurenic Ac | 2021 |
2 other studies available for kynurenic acid and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling.
Topics: Animals; Colitis; Crohn Disease; Fibrosis; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammator | 2022 |
[Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease].
Topics: Administration, Oral; Animals; Biomarkers; Colitis; Disease Models, Animal; Excitatory Amino Acid An | 2012 |